Citigroup analyst Ashwin Shirvaikar maintains Genpact (NYSE:G) with a Buy and raises the price target from $52 to $54.
NanoVibronix Q1 Sales $272.00K Up From $103.00K YoY
NanoVibronix (NASDAQ:NAOV) reported $272.00 thousand in sales this quarter. This is a 164.08 percent increase over sales of $103.00 thousand the same period last year.